Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines
Clinical trial NCT00478816 · COMPLETED
Trial details
- NCT number
- NCT00478816
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2009-02-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.